Zhejiang Jolly Pharmaceutical Co.,LTD (SHE:300181)
China · Delayed Price · Currency is CNY 12.83
-0.21 (-1.61%)
Jun 18, 2026, 3:04 PM CST
SHE:300181 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 8,894 | 11,202 | 10,545 | 7,477 | 7,484 | 7,097 | |
Market Cap Growth | -22.95% | 6.24% | 41.03% | -0.09% | 5.46% | 97.63% |
Enterprise Value | 9,011 | 11,238 | 10,199 | 6,742 | 7,536 | 7,203 |
Last Close Price | 12.83 | 15.76 | 14.44 | 9.73 | 9.52 | 10.15 |
PE Ratio | 13.70 | 17.73 | 20.77 | 19.52 | 27.41 | 39.56 |
Forward PE | 12.34 | 61.41 | 61.41 | 61.41 | 61.41 | 61.41 |
PS Ratio | 2.86 | 3.68 | 4.09 | 3.85 | 4.15 | 4.87 |
PB Ratio | 2.55 | 3.46 | 3.74 | 2.70 | 2.71 | 3.58 |
P/TBV Ratio | 3.15 | 3.78 | 4.11 | 2.96 | 2.98 | 4.30 |
P/FCF Ratio | 25.00 | 89.87 | 308.69 | 47.70 | 53.24 | 68.34 |
P/OCF Ratio | 15.62 | 27.20 | 35.50 | 25.92 | 23.49 | 28.18 |
EV/Sales Ratio | 2.89 | 3.70 | 3.96 | 3.47 | 4.18 | 4.94 |
EV/EBITDA Ratio | 10.49 | 13.61 | 15.48 | 13.95 | 19.92 | 25.92 |
EV/EBIT Ratio | 11.58 | 14.97 | 17.27 | 15.99 | 23.43 | 32.12 |
EV/FCF Ratio | 25.33 | 90.15 | 298.56 | 43.01 | 53.62 | 69.37 |
Debt / Equity Ratio | 0.22 | 0.21 | 0.15 | 0.08 | 0.06 | 0.10 |
Debt / EBITDA Ratio | 0.89 | 0.83 | 0.65 | 0.46 | 0.45 | 0.73 |
Debt / FCF Ratio | 2.15 | 5.55 | 12.58 | 1.42 | 1.23 | 1.99 |
Net Debt / Equity Ratio | 0.01 | 0.00 | -0.13 | -0.31 | -0.33 | -0.05 |
Net Debt / EBITDA Ratio | 0.06 | 0.01 | -0.57 | -1.78 | -2.43 | -0.33 |
Net Debt / FCF Ratio | 0.14 | 0.09 | -10.98 | -5.49 | -6.54 | -0.88 |
Asset Turnover | 0.63 | 0.70 | 0.68 | 0.53 | 0.56 | 0.56 |
Inventory Turnover | 2.27 | 2.23 | 2.14 | 1.65 | 1.81 | 1.77 |
Quick Ratio | 1.19 | 1.37 | 1.52 | 2.04 | 2.16 | 1.13 |
Current Ratio | 1.55 | 1.79 | 2.06 | 2.59 | 2.60 | 1.61 |
Return on Equity (ROE) | 19.81% | 21.20% | 18.45% | 14.12% | 12.04% | 10.37% |
Return on Assets (ROA) | 9.83% | 10.78% | 9.69% | 7.25% | 6.29% | 5.37% |
Return on Invested Capital (ROIC) | 19.43% | 22.40% | 23.44% | 19.66% | 15.19% | 10.63% |
Return on Capital Employed (ROCE) | 21.30% | 22.30% | 20.10% | 14.90% | 11.10% | 10.40% |
Earnings Yield | 7.31% | 5.64% | 4.82% | 5.12% | 3.65% | 2.53% |
FCF Yield | 4.00% | 1.11% | 0.32% | 2.10% | 1.88% | 1.46% |
Dividend Yield | 2.68% | 2.22% | 4.15% | 4.62% | 3.15% | 1.97% |
Payout Ratio | 64.17% | 67.08% | 63.18% | 55.65% | 53.17% | 39.17% |
Buyback Yield / Dilution | 0.16% | 0.17% | 0.10% | -14.76% | 1.93% | -1.64% |
Total Shareholder Return | 2.82% | 2.38% | 4.25% | -10.14% | 5.08% | 0.33% |